Biotechnology Industry Overview
The Biotechnology industry involves the use of living organisms, cells or biological processes to develop and manufacture new products that improve healthcare, agriculture, and industry. It includes genetically modified crop production, new drug development, and advanced diagnostics. Many biotech products are the result of genetic engineering, using cutting-edge technology to manipulate DNA to create new products, such as synthetic insulin or cancer-fighting drugs.
Public Companies in this Industry
Ticker | Company | Market Cap | Country |
---|---|---|---|
068270 | Celltrion Inc | $22t | Korea |
NOVO-B | Novo Nordisk A/S | $2t | Denmark |
4974 | Takara Bio Inc | $208b | Japan |
VRTX | Vertex Pharmaceuticals Inc | $109b | USA |
603392 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd | $107b | China |
REGN | Regeneron Pharmaceuticals Inc | $105b | USA |
300759 | Pharmaron Beijing Co Ltd | $55b | China |
002821 | Asymchem Laboratories Tian Jin Co Ltd | $52b | China |
300957 | Yunnan Botanee Bio-Technology Group Co Ltd | $52b | China |
MRNA | Moderna Inc | $45b | USA |
002252 | Shanghai RAAS Blood Products Co Ltd Class A | $45b | China |
002007 | Hualan Biological EngineeringInc | $45b | China |
SGEN | Seagen Inc | $43b | USA |
1548 | Genscript Biotech Corp | $42b | Hong Kong |
688180 | Shanghai Junshi Biosciences Co Ltd | $41b | China |
603233 | Dashenlin Pharm Grp Co Ltd | $35b | China |
BNTX | BioNTech SE | $22b | USA |
ARGX | argenx NV ADR | $21b | USA |
GMAB | Genmab AS | $18.82b | USA |
ALNY | Alnylam Pharmaceuticals Inc | $18.68b | USA |
BGNE | BeiGene Ltd | $16.82b | USA |
BMRN | Biomarin Pharmaceutical Inc | $15.11b | USA |
UCB | UCB SA | $15.04b | Belgium |
TECH | Bio-Techne Corp | $12.73b | USA |
UTHR | United Therapeutics Corporation | $12.24b | USA |
RPRX | Royalty Pharma plc | $12.06b | USA |
INCY | Incyte Corporation | $11.83b | USA |
SRPT | Sarepta Therapeutics Inc | $11.60b | USA |
KRTX | Karuna Therapeutics Inc | $11.38b | USA |
RXDX | Prometheus Biosciences Inc | $9.50b | USA |
ROIV | Roivant Sciences Ltd. Common Shares | $7.70b | USA |
ASND | Ascendis Pharma AS | $7.63b | USA |
LEGN | Legend Biotech Corp | $7.24b | USA |
IMGN | ImmunoGen Inc | $7.06b | USA |
EXEL | Exelixis Inc | $6.93b | USA |
JAZZ | Jazz Pharmaceuticals plc | $6.74b | USA |
CERE | Cerevel Therapeutics Holdings Inc | $6.61b | USA |
BPMC | Blueprint Medicines Corp | $6.40b | USA |
CYTK | Cytokinetics Inc | $5.91b | USA |
HALO | Halozyme Therapeutics Inc | $5.84b | USA |
VKTX | Viking Therapeutics Inc | $5.77b | USA |
IONS | Ionis Pharmaceuticals Inc | $5.59b | USA |
RETA | Reata Pharmaceuticals Inc | $5.53b | USA |
ISEE | IVERIC bio Inc | $5.48b | USA |
CRBP | Corbus Pharmaceuticals Holdings, Inc | $5.38b | USA |
PCVX | Vaxcyte Inc | $5.22b | USA |
APLS | Apellis Pharmaceuticals Inc | $4.67b | USA |
BBIO | BridgeBio Pharma Inc | $4.66b | USA |
CRSP | Crispr Therapeutics AG | $4.02b | USA |
KRYS | Krystal Biotech Inc | $3.99b | USA |
RVMD | Revolution Medicines Inc | $3.95b | USA |
MNMD | Mind Medicine (MindMed) Inc | $3.90b | USA |
IMVT | Immunovant Inc | $3.83b | USA |
HCM | HUTCHMED (China) Limited | $3.76b | USA |
MDGL | Madrigal Pharmaceuticals Inc | $3.72b | USA |
NK | NantKwest Inc | $3.71b | USA |
INSM | Insmed Inc | $3.54b | USA |
IBRX | Immunitybio Inc | $3.54b | USA |
MRTX | Mirati Ther | $3.41b | USA |
NUVL | Nuvalent Inc | $3.34b | USA |
SMMT | Summit Therapeutics PLC | $3.24b | USA |
AGEN | Agenus Inc | $3.20b | USA |
CBAY | Cymabay Therapeu | $3.16b | USA |
AXSM | Axsome Therapeutics Inc | $3.15b | USA |
ALPN | Alpine Immune Sciences Inc | $2.98b | USA |
CORT | Corcept Therapeutics Incorporated | $2.92b | USA |
RARE | Ultragenyx | $2.87b | USA |
IMCR | Immunocore Holdings Ltd | $2.84b | USA |
INO | Inovio Pharmaceuticals Inc | $2.77b | USA |
KDNY | Chinook Therapeutics Inc | $2.66b | USA |
FOLD | Amicus Therapeutics Inc | $2.61b | USA |
CRNX | Crinetics Pharmaceuticals Inc | $2.59b | USA |
SWTX | SpringWorks Therapeutics Inc | $2.56b | USA |
XENE | Xenon Pharmaceuticals Inc | $2.56b | USA |
DNLI | Denali Therapeutics Inc | $2.50b | USA |
ACAD | ACADIA Pharmaceuticals Inc | $2.47b | USA |
IOVA | Iovance Biotherapeutics Inc | $2.46b | USA |
MOR | MorphoSys AG | $2.46b | USA |
TGTX | TG Therapeutics Inc | $2.43b | USA |
ARWR | Arrowhead Pharmaceuticals Inc | $2.39b | USA |
PTCT | PTC Therapeutics Inc | $2.38b | USA |
ACLX | Arcellx Inc | $2.35b | USA |
BHVN | Biohaven Pharmaceutical Holding Company Ltd | $2.34b | USA |
VCEL | Vericel Corp Ord | $2.28b | USA |
PRVB | Provention Bio Inc | $2.28b | USA |
DICE | Dice Molecules Holdings LLC | $2.27b | USA |
RYTM | Rhythm Pharmaceuticals Inc | $2.22b | USA |
PRAX | Praxis Precision Medicines Inc | $2.19b | USA |
VSTM | Verastem Inc | $2.16b | USA |
NTLA | Intellia Therapeutics Inc | $2.15b | USA |
KYMR | Kymera Therapeutics Inc | $2.09b | USA |
MRUS | Merus BV | $2.06b | USA |
JANX | Janux Therapeutics Inc. Common Stock | $2.04b | USA |
IDYA | Ideaya Biosciences Inc | $1.99b | USA |
ZLAB | Zai Lab Ltd | $1.97b | USA |
ADMA | ADMA Biologics Inc | $1.95b | USA |
CLDX | Celldex Therapeutics Inc | $1.88b | USA |
GLPG | Galapagos NV ADR | $1.88b | USA |
BLU | BELLUS Health Inc. | $1.87b | USA |
RNA | Avidity Biosciences Inc | $1.84b | USA |